Decreasing the amount of Reelin significantly protected against disease symptoms and promoted recovery in symptomatic animal models of multiple sclerosis. Reelin levels appear to correlate with MS severity and stages. Researchers report lowering levels of the protein could be a potential avenue of treatment for the autoimmune disorder.
Study reports a link between levels of GlycA, an inflammatory molecule in the blood, and an increased risk of depression symptoms. Researchers also outline specific symptoms associated with menopause and an increased likelihood of developing depression.
A new study may help shed light on the diversity of dementias linked to tau protein aggregation.
Using machine learning to analyze blood samples, researchers have identified a group of new biomarkers that could lead to early diagnosis of autism.
Combining neuroimaging and artificial intelligence, researchers identified novel brain signatures unique to the response of each antidepressant.
A neurotoxin found in snake venom allowed researchers to uncover a detailed shape of nicotinic receptors involved in muscle contractions.
Researchers report EEG technology can help to predict the onset of epileptic seizures up to four minutes in advance. Additionally, acetate, an edible acid, may help to prevent seizures if they are detected with enough notice.
Researchers report single tau proteins have different shapes, and the folds of the molecules could help doctors to predict which type of dementia a person is likely to suffer from.
A detailed 3D structure of nicotinic acetylcholine receptors could help pave the way to developing new treatments for nicotine addiction, researchers report.
A new DNA vaccine tested in mice significantly reduces tau and amyloid beta, two proteins implicated in Alzheimer's disease. The findings, researchers say, may pave the way for clinical trials in humans with the neurodegenerative disease.
A new Science study sheds light on how the gut microbiota interacts with circadian rhythm to impact metabolism. Researchers say the finding could help explain why those who work night shifts have higher rates of metabolic diseases.
Study identified 300 "hub genes" that appear to control separate gene networks in brain tissue samples. The SAMD3 gene appears to be a master regulator to control the activity of many of the gene hubs and the genes the hubs control.